Daxor Corporation (DXR) is a Medical instruments supplies company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Daxor Corporation in 2026. The next earnings report is expected on March 10, 2027.
Next earnings date
10 Mar 2027
In 202 days
EPS estimate
—
Revenue estimate
—
Past earnings
No dividend history available.
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Daxor Corporation (DXR) is scheduled to report earnings on March 10, 2027.
Daxor Corporation (DXR) last reported earnings on August 20, 2026.
Daxor Corporation (DXR) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.